Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire.

IF 2.7 3区医学 Q2 DERMATOLOGY

Dermatology Pub Date : 2025-07-07 DOI:10.1159/000539758

Theodora Kanni, Sofia Ktena, Konstantinos Leventogiannis, Christina Damoulari, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Evangelos J Giamarellos-Bourboulis

{"title":"Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire.","authors":"Theodora Kanni, Sofia Ktena, Konstantinos Leventogiannis, Christina Damoulari, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Evangelos J Giamarellos-Bourboulis","doi":"10.1159/000539758","DOIUrl":null,"url":null,"abstract":"Introduction: Prevalence of hidradenitis suppurativa (HS) differs between countries and the worldwide prevalence of the disease remains unknown. Prevalence of HS has never been studied in Greece. The aim of this study was to estimate the HS prevalence in Athens, the capital of Greece.Method: Healthy adults accompanying patients to the outpatient department of internal medicine of ATTIKON University Hospital were approached by physicians familiar with HS. All eligible persons signed an informed consent form and answered the questionnaire. This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative and therefore followed the objective and approach previously published by Bouazzi et al. [Dermatology. 2024 Feb;240(3):369-75].Results: Out of 553 participants, 20 screened positive for HS. Of these, only one was diagnosed with HS, resulting in a prevalence of 0.18% (95% CI, 0.03%-1.02%). The sensitivity of the HS questionnaire was 100%, specificity 75.9%, positive predictive value 5.0%, and negative predictive value 100%.Conclusion: The prevalence of HS in our study was relatively low. A further study with a larger number of participants is needed to confirm the findings.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233989/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539758","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Prevalence of hidradenitis suppurativa (HS) differs between countries and the worldwide prevalence of the disease remains unknown. Prevalence of HS has never been studied in Greece. The aim of this study was to estimate the HS prevalence in Athens, the capital of Greece.

Method: Healthy adults accompanying patients to the outpatient department of internal medicine of ATTIKON University Hospital were approached by physicians familiar with HS. All eligible persons signed an informed consent form and answered the questionnaire. This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative and therefore followed the objective and approach previously published by Bouazzi et al. [Dermatology. 2024 Feb;240(3):369-75].

Results: Out of 553 participants, 20 screened positive for HS. Of these, only one was diagnosed with HS, resulting in a prevalence of 0.18% (95% CI, 0.03%-1.02%). The sensitivity of the HS questionnaire was 100%, specificity 75.9%, positive predictive value 5.0%, and negative predictive value 100%.

Conclusion: The prevalence of HS in our study was relatively low. A further study with a larger number of participants is needed to confirm the findings.

查看原文本刊更多论文

希腊雅典化脓性汗腺炎的流行：一项基于有效问卷的横断面研究。

简介：化脓性汗腺炎（HS）的患病率在不同国家之间存在差异，全球患病率仍不清楚。希腊从未研究过HS的流行情况。本研究的目的是估计希腊首都雅典的HS患病率。方法：在ATTIKON大学医院内科门诊，由熟悉HS的医生与陪同患者的健康成人进行接触。所有符合条件的人都签署了知情同意书并回答了问卷。本研究是全球化脓性汗腺炎地图集（GHiSA）倡议的一部分，因此遵循了Bouazzi等人先前发表的目标和方法。2024年2月,240(3):369 - 75)。结果：在553名参与者中，20人筛查出HS阳性。其中，只有一人被诊断为HS，导致患病率为0.18% （95% CI, 0.03%-1.02%）。HS问卷的敏感性为100%，特异性为75.9%，阳性预测值为5.0%，阴性预测值为100%。结论：本研究HS患病率较低。需要更多参与者的进一步研究来证实这些发现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dermatology 医学-皮肤病学

CiteScore

6.40

自引率

2.90%

发文量

审稿时长

1 months

期刊介绍： Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.